ras mutation and expression of the ras-regulated genes osteopontin and cathepsin L in human esophageal cancer

International Journal of Cancer

Volumn 72, Issue 5, 1997, Pages 739-745

  Casson, Alan G ^a,e   Wilson, Sylvia M ^b   Mccart, J Andrea ^b   O'Malley, Frances P ^b   Ozcelik, Hilmi ^c   Tsao, Ming Sound ^d   Chambers, Ann F ^b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN L; GENE PRODUCT; OSTEOPONTIN; PROTEIN P53; RAS PROTEIN; RNA 18S;

ARTICLE; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; METASTASIS; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN INDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; ENDOPEPTIDASES; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, P53; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUTATION; OSTEOPONTIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RNA, MESSENGER; SEQUENCE ANALYSIS; SIALOGLYCOPROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030843339     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970904)72:5<739::AID-IJC6>3.0.CO;2-T     Document Type: Article

References (21)

1. ALLRED, D.C., CLARK, G.M., ELLEDGE, R., FUQUA, S.A.W., BROWN, R.W., CHAMNESS, G.C., OSBORNE, C.K. and MCGUIRE, W.L., Association of p53 protein expression with cell proliferation rate and clinical outcome in node-negative breast cancer. J. nat. Cancer Inst., 85, 200-206 (1993).
2. BAUTISTA, D.S., XUAN, J.W., HOTA, C., CHAMBERS, A.F. and HARRIS, J.F., Inhibition of RGD-mediated cell adhesion to osteopontin by a monoclonal antibody against osteopontin. J. biol. Chem., 269, 23280-23285 (1994).
3. BEHREND, E.I., CRAIG, A.M., WILSON, S.M., DENHARDT, D.T. and CHAMBERS, A.F., Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Res., 54, 832-837 (1994).
4. CASSON, A.G., KERKVLIET, N. and O'MALLEY, F., Prognostic value of p53 protein in esophageal adenocarcinoma. J. surg. Oncol., 60, 5-11 (1995).
5. CASSON, A.G., MUKHOPADHYAY, T., CLEARY, K.R., RO, J.Y., LEVIN, B. and ROTH, J.A., p53 mutations in Barrett's epithelium and esophageal cancer. Cancer Res., 51, 4495-4499 (1991).
6. CHAMBERS, A.F., BEHREND, E.I., WILSON, S.M. and DENHARDT, D.T., Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells. Anticancer Res., 12, 43-48 (1992a).
7. CHAMBERS, A.F., COLELLA, R., DENHARDT, D.T. and WILSON, S.M., Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells. Mol. Carcinogenesis, 5, 238-245 (1992b).
8. CHAMBERS, A.F., WILSON, S.M., KERKVLIET, N., O'MALLEY, F.P., HARRIS, J.F. and CASSON, A.G., Osteopontin expression in lung cancer. Lung Cancer, 15, 311-323 (1996).
9. DENHARDT, D.T. and GUO, X., Osteopontin: a protein with diverse functions. FASEB J., 7, 1475-1482 (1993).
10. DENHARDT, D.T., HAMILTON, R.T. and PARFETT, C.L., Close relationship of the major excreted protein of transformed murine fibroblasts to thiol-dependent cathepsins. Cancer Res., 46, 4590-4593 (1986).
11. GALIANA, C., FUSCO, A., MARTEL, N., NISHIHIRA, T., HIROHASHI, S. and YAMASAKI, H., Possible role of activated ras genes in human esophageal carcinogenesis. Int. J. Cancer, 54, 978-982 (1993).
12. GALIANA, C., LOZANO, J.-C., BANCEL, B., NAKAZAWA, H. and YAMASAKI, H., High frequency of Ki-ras amplification and p53 gene mutations in adenocarcinomas of the human esophagus. Mol Carcinogenesis, 14, 286-293 (1995).
13. GUO, X., ZHANG, Y.P., MITCHELL, D.A., DENHARDT, D.T. and CHAMBERS, A.F., Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with metastatic potential. Mol. cell. Biol., 15, 476-487 (1995).
14. HOLLSTEIN, M.C., METCALF, R.A., WELSH, J.A., MONTESANO, R. and HARRIS, C.C., Frequent mutation of the p53 gene in human esophageal cancer. Proc. nat. Acad. Sci. (Wash.), 87, 9958-9961 (1990).
15. LOSANO, J.-C., NAKAZAWA, H., CROS, M.-P., CABRAL, R. and YAMASAKI, H., G → A mutations in p53 and Ha-ras genes in esophageal papillomas induced by N-nitrosomethylbenzylamine in two strains of rats. Mol. Carcinogenesis, 9, 33-39 (1994).
16. MONTESANO, R., HOLLSTEIN, M. and HAINAUT, P., Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int. J. Cancer (Pred. Oncol.), 69, 225-235 (1996).
17. OZCELIK, H., MOUSSES, S. and ANDRULIS, I.L., Low levels of expression of an inhibitor of cyclin-dependent kinases (CIP1/WAF1) in primary breast carcinomas with p53 mutations. Clin. Cancer Res., 1, 907-912 (1995).
18. RUOL, A., STEPHENS, J.K., MICHELASSI, F., SEGALIN, A., CHIAREILI, S., PERACCHIA, A., SKINNER, D.B. and LITTLE, A.G., Expression of ras oncogene p21 protein in esophageal squamous cell carcinoma. J. surg. Oncol., 44, 142-145 (1990).
19. SORSDAHL, K., CASSON, A.G., TROSTER, M., VAN MEYEL, D., INCULET, R. and CHAMBERS, A.F., P53 and ras gene expression in human esophageal cancer and Barrett's epithelium: a prospective study. Cancer Detect Prev., 18, 179-185 (1994).
20. WANG, Y., YOU, M., REYNOLDS, S.H., STONER, G.D. and ANDERSON, M.W., Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine. Cancer Res., 50, 1591-1595 (1990).
21. YOUNG, M.F., KERR, J.M., TERMINE, J.D., WEWER, U.M., WANG, M.G., MCBRIDE, O.W. and FISHER, L.W., cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN). Genomics, 7, 491-502 (1990).